Reports for LAMIVUDINE
Ingredient
LAMIVUDINE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-20 | 2023-08-18 | 195900 |
| TRIZIVIR | 300MG 300MG 150MG | TABLET | Resolved | 2019-08-02 | 2021-12-08 | 90619 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
| HEPTOVIR | 5MG | SOLUTION | Discontinued | 2022-05-13 | 2022-07-22 | 160503 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |
| TRIZIVIR | 300MG 300MG 150MG | TABLET | Discontinued | 2019-09-18 | 2019-09-18 | 94278 |
Showing 1 to 8 of 8